Dr. Reddy's Laboratories (DRREDDY)
Held previously, not currently in the book. NSE ticker DRREDDY, sector Pharmaceuticals, industry Generic Drugs.
See current holdings Rebalance historyWhere Dr. Reddy's Laboratories sits in the RupeeCase Allcap model
Dr. Reddy's Laboratories has appeared in the RupeeCase Allcap book in at least one prior cycle. It was screened out at the most recent rebalance on 2026-04-20. If the composite momentum score climbs back into the top decile of the Nifty 50, the name will be picked up at a future fortnightly review without any discretionary input.
Pharma names cluster around product-launch calendars and USFDA observation cycles. The screen treats the sleeve as uncorrelated to the broad Nifty, so it can lift during risk-off periods.
Rebalance history
OUT Exited on 2026-04-20
IN Added on 2026-04-13
RETAINED Held through 2026-03-30 rebalance
How the selection works
The RupeeCase Allcap strategy picks ten stocks from the Nifty 50 on a fortnightly cadence. Selection is driven by a composite of price momentum (6 and 12 month), earnings revisions, and balance sheet quality. Position sizes are set inversely to 90 day volatility. If a stock falls out of the top decile of the composite, it is removed at the next cycle and replaced by the highest ranked name currently outside the book.
Because the screen is rules based, the fundamentals of Dr. Reddy's Laboratories do not override the score. The book will hold this name only when the composite puts it in the top 10 on the rebalance date.